Donor-Derived Cell Free DNA: Is It All the Same? (original) (raw)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review

Marta Zalewska

Journal of Clinical Medicine, 2021

View PDFchevron_right

The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation

Laxmi Dongur

Journal of Personalized Medicine

View PDFchevron_right

Cell-Free DNA and Active Rejection in Kidney Allografts

Anthony Langone

Journal of the American Society of Nephrology : JASN, 2017

View PDFchevron_right

Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection

Hossein Tabriziani

Journal of the American Society of Nephrology, 2021

View PDFchevron_right

Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study

Björn Nashan

PLOS Medicine, 2017

View PDFchevron_right

Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study

Anastasia Butskova

American Journal of Transplantation, 2019

View PDFchevron_right

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients

Anthony Langone

Transplantation direct, 2018

View PDFchevron_right

Cell-Free DNA in Pediatric Solid Organ Transplantation Using a New Detection Method of Separating Donor-Derived from Recipient Cell-Free DNA

Evgenia Preka

Clinical Chemistry, 2020

View PDFchevron_right

Cell-free DNA in the surveillance of heart transplant rejection

ganapathy subramaniam

Indian Journal of Thoracic and Cardiovascular Surgery, 2021

View PDFchevron_right

The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation

Benedicte De Winter

Nephrology Dialysis Transplantation, 2019

View PDFchevron_right

Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects

Leif Nielsen

PLOS ONE, 2023

View PDFchevron_right

An Algorithm Measuring Donor Cell-Free DNA in Plasma of Cellular and Solid Organ Transplant Recipients That Does Not Require Donor or Recipient Genotyping

Umair Sajid

Frontiers in Cardiovascular Medicine, 2016

View PDFchevron_right

Relationship Between Donor Derived Cell-Free DNA and Tissue-Based Rejection-Related Transcripts In Heart Transplantation

Ahsan Usmani

View PDFchevron_right

Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study

Sanjiv Anand

Kidney International, 2021

View PDFchevron_right

Donor Derived Cell Free DNA Kinetics Post Kidney Transplant Biopsy

safa alakhdhair, Sami Alasfar

2020

View PDFchevron_right

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation

Charles Marboe

EBioMedicine

View PDFchevron_right

Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation

Kenneth Knecht

The Journal of Heart and Lung Transplantation, 2019

View PDFchevron_right

Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications

Anthony Langone

The Journal of Applied Laboratory Medicine: An AACC Publication, 2017

View PDFchevron_right

Utility of Cell-Free DNA Detection in Transplant Oncology

Tejaswini Reddy

Cancers, 2022

View PDFchevron_right

Early changes in cell‐free DNA levels in newly transplanted heart transplant patients

Karl Stamm

Pediatric Transplantation

View PDFchevron_right

Donor DNA can be detected in recipient tissues during rejection of allograft

Waldemar Olszewski

Transplant International, 2000

View PDFchevron_right

Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation

Amalia Rubio

Journal of Clinical Medicine

View PDFchevron_right

Single Center “Snapshot” Experience With Donor-Derived Cell-Free DNA After Lung Transplantation

Deborah Levine

Biomarker Insights, 2020

View PDFchevron_right

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR

Minnie Sarwal

Journal of Clinical Medicine

View PDFchevron_right

Digital Droplet PCR for Rapid Quantification of Donor DNA in the Circulation of Transplant Recipients as a Potential Universal Biomarker of Graft Injury

Onnen Moerer

Clinical Chemistry, 2013

View PDFchevron_right

Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection

Thomas Snyder

Science Translational Medicine, 2014

View PDFchevron_right

Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome

Isabel Legaz

International Journal of Molecular Sciences

View PDFchevron_right

Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study

Mario Sanabria

Frontiers in Cardiovascular Medicine

View PDFchevron_right

High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury

Keith Melancon

American Journal of Transplantation, 2020

View PDFchevron_right